MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Movement Disorders in Post Stroke Patients: A Retrospective Analysis

    M. Christie, V. Laticevschi, R. Mehanna (Houston, TX, USA)

    Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…
  • 2019 International Congress

    Language characteristics of picture description task by Hebrew speaking patients with Parkinson’s disease

    D. Shpunt, S. Naor, N. Diamant, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich, Y. Manor (Tel Aviv, Israel)

    Objective: To characterize picture description by patients with PD Hebrew speakers. Background: Non-motor symptoms in Parkinson’s disease (PD) such as cognitive decline, depression and language…
  • 2019 International Congress

    The trace of substantia nigra hyperechogenicity: a clinical observation

    A. Alonso-Canovas, JL. Sendon-Moreno, G. Garcia-Ribas, N. Monterde-Gonzalez, C. Jara-Laguna, JC. Martinez-Castrillo, J. Masjuan (Madrid, Spain)

    Objective: To present an empirical observation regarding transcranial ultrasound in movement disorders and scalp sebum smear. Background: Transcranial ultrasound (TUS) detects substantia nigra hyperechogenicity (SN+) in…
  • 2019 International Congress

    Case Report: Co-occurrence of Motor Neuron Disease and Parkinsonism

    B. Barton (Chicago, IL, USA)

    Objective: Explore possible links between degenerative parkinsonism and motor neuron disease Background: A 50 year-old man developed with the cardinal features of parkinsonism.  History was…
  • 2019 International Congress

    Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

    P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

    Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
  • 2019 International Congress

    Neuroanatomical and clinical predictors of pain in patients with early de novo Parkinson’s disease

    . Cousins, H. Wilson, T. Yousaf, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: We investigated associations between clinical features, neuroanatomical changes and pain in early de novo Parkinson’s disease (PD) patients. Background: Pain is a common and…
  • 2019 International Congress

    Hip fracture in patients with a new diagnosis of Parkinson’s Disease – estimating the 5-year risk

    L. Evans, A. Johansen, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

    Objective: We set out to quantify the five-year risk of hip fracture for a cohort of 780 patients for whom a new diagnosis of Parkinson’s…
  • 2019 International Congress

    Bilateral vestibulopathy due to neurosarcoidosis mimicking Parkinsonian syndrome

    M. Hamaguchi, H. Fujita, K. Suzuki (Utsunomiya, Japan)

    Objective: We here describe a patient with neurosarcoidosis presenting with progressive gait disturbance that mimics Parkinsonian syndrome. Background: Neurosarcoidosis can show various neurological complications; however,…
  • 2019 International Congress

    Impact of OFF periods on aspects of employment for people with Parkinson’s disease

    I. Iresha Abeynayake, L. Marinucci, M. Klingler, C. Kenney (Aardsley, NY, USA)

    Objective: To characterize the impact of OFF periods on aspects of employment for people with Parkinson’s disease (PD) who have OFF periods compared to those…
  • 2019 International Congress

    Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study

    C. Koros, AM. Simitsi, M. Stamelou, D. Papadimitriou, A. Bougea, I. Pachi, N. Papagiannakis, A. Prentakis, E. Angelopoulou, R. Antonellou, M. Bozi, X. Geronicola Trapali, L. Stefanis (Athens, Greece)

    Objective: To determine whether there are longitudinal differences in serum uric acid level among sporadic Parkinson’s disease (PD) patients, PD patients harboring the p.A53T mutation…
  • « Previous Page
  • 1
  • …
  • 190
  • 191
  • 192
  • 193
  • 194
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley